Indications:
● Daily maintenance therapy for bronchospasm associated with COPD.
● Maintenance treatment of asthma in individuals aged 6 and above.
Administration Guidelines:
Dosage:
● The recommended dose of Spiriva Respimat is two inhalations once daily. Consistency in the timing of the administered dose is crucial for optimal results.
Method of Administration:
● It should be administered via the Spiriva Respimat inhaler after proper training on the inhalation technique to ensure the medication is effectively delivered to the lungs.
Dosage Form:
● Respimat Inhaler: This inhaler utilizes a spring-powered mechanism to deliver a specific amount of tiotropium in a fine mist, inhaled into the lungs.
Safety Preclusions
Pregnancy and Breastfeeding:
● Potential risks and benefits should be evaluated before using Spiriva Respimat during pregnancy.
● It has not been established whether tiotropium passes into breast milk; hence, caution is recommended when administered to breastfeeding women.
Long-term Use:
● Spiriva Respimat is intended for sustained treatment. Regular monitoring by a healthcare provider is advised to check for continued effectiveness and the emergence of adverse reactions.
Drug Interactions:
● Anticholinergic drugs may have additive effects when used in conjunction with Spiriva Respimat. Patients must disclose all medications being taken to a healthcare professional.
|
